More From Sushree Mohanty
Archer Daniels Midland Reports Another Disappointing Quarter
In 3Q15, Archer Daniels Midland earned $684 million in operating profit, down $257 million from 3Q14. Its net revenue for the quarter was $16.6 billion.
What Do Analysts Recommend for Archer Daniels Midland?
Now, ~8% gave Archer Daniels Midland a “buy” rating. No analysts rated it a “sell.” The average target price for the company fell to $36.60 as of April 26.
Analyzing the Expectations for Cal-Maine Foods in Fiscal 3Q16
Cal-Maine Foods will report its fiscal 3Q16 results on March 28. Cal-Maine’s stock has gained 2% since its last quarter earnings release on December 23, 2015.
Hormel’s Specialty Food Segment Performed Well in 3Q15
Hormel Foods Corporation, based in Austin, Minnesota, is a multinational manufacturer and marketer of consumer-branded food and meat products.
Market Conditions Continued to Impact ADM’s Revenue in 2Q16
Archer Daniels Midland’s (ADM) revenue fell 9% YoY (year-over-year) to $15.63 billion in 2Q16—compared to $17.19 billion in the same quarter last year.
Looking at Cal-Maine Foods’ Variable Dividend Policy
Cal-Maine Foods has a dividend yield of 4.4% as of March 29, 2016. Management raised the dividend at an average annual rate of 15.3% over five years.
Farmer Brothers’ Relocation Plans and Improved Gross Margin
Farmer Brothers’ (FARM) gross profit in 4Q15 increased by $3.7 million, or 8.2%, to $49.2 million. It recorded a 4Q14 gross margin of $45.5 million.
Diamond Foods’ Earnings Missed Estimates in Fiscal 1Q16
Diamond Foods missed estimates by 12.5% for the first time in the last five quarters. It had surpassed estimates for EPS in all the four quarters of fiscal 2015.
What Contributed to Hormel Foods’ 3Q15 Segment Performance?
Refrigerated Foods constituted 48% of Hormel Food’s net sales and 41% of its total segment operating profit in 3Q15.
Kraft Heinz Reported 2Q15 Results after the Merger
On August 10, the Kraft Heinz Company reported its 2Q15 results for Kraft Foods and H.J. Heinz for the periods ending June 27 and June 28, respectively.
What Diamond Foods’ Segments Contributed in Fiscal 1Q16
Diamond Foods operates in two segments that are the Snack segment and the Nut segment. The latter consists of the Emerald and Diamond of California brands.
Analysts Expect Positive Revenue Growth in Fiscal 2Q16
The revenue estimate for Farmer Brothers in fiscal 2Q16 isn’t as high. However, it’s still positive. Analysts predict revenue of $145.3 million for fiscal 2Q16
Hain Celestial Group Prepares to Report 1Q16 Results
The Hain Celestial Group’s net sales in the United States rose 3% YoY (year-over-year) to $332.8 million in the last quarter. Net sales in the United Kingdom fell 7.8% to $184.90 million.
Will Bunge’s Acquisitions Help Revive Its Segment Margins?
Bunge North America, the North American operating segment of Bunge Limited (BG), announced that it had acquired Whole Harvest Foods.
Marijuana Movement: Why Do Celebrities Support It?
Marijuana is gaining more and more attention. What’s caught the most attention is that many celebrities are joining the growing support movement.
How’s ADM Advancing with Its Portfolio Management Strategy?
As part of its portfolio management strategy, Archer Daniels Midland (ADM) sold its Brazilian sugar cane ethanol operations.
Will IIPR Still Be an Investor Favorite Post Q3 Earnings?
Innovative Industrial Properties (IIPR) is set to report its third-quarter results tomorrow. IIPR stock, up 67.2% year-to-date, has been investor favorite.
What Does President Trump Think about Marijuana?
President Trump hasn’t directly supported or opposed marijuana. In the past, he said that marijuana makes people “lose IQ points.”
July Jobs Report: Strong Numbers amid Trade Tension
The Department of Labor released the July jobs report on Friday morning. Amid the trade tensions, the July jobs report brought relief.
Aurora Cannabis’s Revenue: Here’s What Analysts Expect
Aurora Cannabis is set to release its fiscal 2020 first-quarter earnings results on November 11. Let’s see what analysts expect for its upcoming quarter.
Marijuana Policy: Can California Shape It for the US?
Marijuana reform has always been important in California, which became the first state to legalize medical marijuana in 1996.
Cannabis Industry Heats Up, Trump Might Ban Vaping
Cannabis legalization is heating up. More states are coming forward to legalize marijuana. Cannabis is also gaining global popularity.
Cannabis Investment: How to Buy ACB, CGC, and Other Stocks
Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.
Cannabis in Mexico: Legalization Bill Is Ready for Voting!
Cannabis legalization is approaching the deadline in Mexico. According to the Supreme Court, the deadline for marijuana legalization is Wednesday.
Mexico Will Attempt to Legalize Marijuana in 2020
Mexico is ready with a revised proposal to legalize marijuana this year. The Supreme Court gave lawmakers until April 30 to submit the new proposal.
Canopy Growth Looks for CEO, Linton Gets a New Role
Canopy Growth took the market by surprise and let CEO Bruce Linton go. After leaving Canopy Growth, Linton joined three companies in an advisory role.
HEXO: Analysts’ Target Price and Ratings
CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars.
Canopy Growth Stock Rises, Oppenheimer Initiates Coverage
Oppenheimer analyst Rupesh Parikh initiated coverage on Canopy Growth stock. The analyst gave a “perform” rating with no target price.
Cronos Group Joins Altria to Bet on Cannabidiol Market
Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group.
Cannabis and Vaping Concerns: Will the Dream Go Up in Smoke?
Cannabis legalization is a vital topic in the US. Meanwhile, vaping related deaths continue to rise. Will vaping concerns kill the US cannabis dream?
How Bunge Is Creating Value from Segment Synergies
Bunge’s (BG) Agribusiness segment processes oilseeds into vegetable oils.
What’s in Store for Consumer Stocks This Week?
Several consumer stocks were downgraded last week
Why Canopy Growth Isn’t Happy with Apple
Apple removed 181 vaping-related apps due to the vape crisis in the US. Canopy Growth is not happy with Apple’s move. Let’s see why.
Aurora Cannabis: What to Expect from Its Q4 Results
Aurora Cannabis should report its fourth-quarter earnings results on Thursday. So far, September has been positive. As of Monday, the stock has gained 8.7%.
Archer Daniels Midland Stock Gained since Its 1Q16 Earnings
Archer Daniels Midland (ADM) is slated to report its 2Q16 results on August 2 before the market opens. The stock has gained 12% since its last quarter results.
South Dakota Plans for Marijuana Legalization amid COVID-19
Marijuana is illegal in South Dakota. However, the state decided to make both recreational and medical marijuana legal this year.
Is Aphria a Good Cannabis Pick for 2020?
Aphria has successfully strengthened its position not only in Canada but also in international markets. The company reported impressive second-quarter results.
Will MedMen Deliver Any Good News in Its Q2 Earnings?
MedMen will report its earnings results for the second quarter of fiscal 2020 on Wednesday. Analysts expect 67.6% YoY revenue growth.
Cannabis 2.0: Aphria Gets Ready for Edibles Market
Cannabis 2.0 legalization will take place in Canada this month. Aphria plans to expand its consumer base in the vape and concentrates business.
Elizabeth Warren Unveils Plan for Marijuana Legalization
According to Warren’s new marijuana plan, the federal legalization process would start within 100 days of her taking office.
Canopy Growth: New Cannabis 2.0 Products amid COVID-19
Canopy Growth (NYSE:CGC)(TSE:WEED) still has investors’ attention despite all that the marijuana industry has gone through.
Medical Marijuana Is Booming in OK, Struggles in OH
Medical marijuana is a hit in Ohio since it allowed it in 2016. Recreational cannabis is still not allowed. Notably, data has shown that Ohio’s medical cannabis industry is booming since it started in 2019. However, the medical cannabis industry is facing some setbacks as well. So, let’s take a look at it. Ohio and […]
Marijuana Industry: Opportunities in California amid COVID-19
Marijuana is an old but growing market in California. Notably, California became the first state to legalize medical marijuana in 1996.
Medical Cannabis in Brazil Is Coming
According to a Reuters report on December 3, Brazil is ready to approve medical cannabis products. Currently, cannabis is illegal in Brazil.
Cannabis Sector 2019 Review and 2020 Outlook
Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.
Marijuana: Will Trump Have an Edge over Biden?
With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization.
Aurora Cannabis: Analysts’ Target Price after Its Earnings
Aurora Cannabis (ACB) reported its fourth-quarter results on September 11. The results disappointed analysts and investors.
Marijuana Legalization: O’Rourke Blazes His 2020 Campaign
Democratic presidential candidate Beto O’Rourke is known for voicing his opinion on federal marijuana legalization. He supports marijuana legalization.
Why Bunge Might Report a Drop in Revenue in 1Q16
Analysts are expecting revenue to be $10.1 billion for fiscal 1Q16. This represents a fall of 6% compared to 1Q15 revenue of $10.8 billion.
Marijuana Legalization: South Dakota Does What Trump Said!
Marijuana legalization is ramping up. Now, South Dakota is taking President Trump’s advice. The state is kicking off a petition to legalize cannabis.
Vaping Concerns Grow, FDA and FTC Investigate Juul
Vaping has become very popular. However, investigations by the FTC and FDA sparked more concerns. Juul’s vaping devices could cause seizures.
Wall Street Analysts’ Take on Bunge before Its 2Q16 Earnings
Around 61% of analysts now rate Bunge as a “buy” and 39% rate it as a “hold.” No analysts rate it as a “sell.”
Aphria: Why Jefferies Recommends a ‘Buy’
Aphria (APHA) reported its results for the first quarter of fiscal 2020 on October 15. Since then, the stock has fallen 7%.
Which Consumer Sector Stocks Lost the Most Last Week?
The Washington-based Costco Wholesale Corporation (COST) announced its fiscal 2Q18 results on March 7 after the market closed.
Canopy Gets Estimates Revised by Analysts for 2020
Canopy Growth (CGC) (WEED) missed analysts’ estimates this year. Analysts had huge expectations from CGC after Canada allowed cannabis in 2018.
Key Consumer Sector Insights for July 24–28, 2017
The 2Q17 earnings season started with a mixed performance. Most stocks in the consumer discretionary and consumer staples space were volatile last week.
Tilray: Are Analysts Optimistic about Its Stock?
After Tilray’s second-quarter earnings, Benchmark reduced its target price to $80 from $120. Cowen and Company reduced the target price to $60 from $150.
Analyzing the Ratings and Recommendations for Hain Celestial
After Hain Celestial’s announcement on August 15 regarding the delay in its results, many firms updated their ratings and recommendations for the stock.
Cannabis 3.0: Is It on the Horizon?
On October 17, Cannabis 2.0 legalized edibles, beverages, and concentrates in Canada. As the country waits for the benefits, is Cannabis 3.0 next?
Hershey Rejects Mondelez’s Takeover Offer, Wall Street Responds
The average broker target price for Hershey has risen to $95.5 from $91.23. This represents an increase of 14% from the stock’s closing price of $109.12 on July 20, 2016.
Analysts’ Outlook for Cronos Group in January
Jefferies reduced the target price for Cronos Group stock to $5.3 from $7.5. The stock’s average target price is set at 12.0 Canadian dollars.
Cannabis in Kansas: Residents Are Taking Action
Currently, 33 states and Washington, D.C., have legalized medical cannabis, but it’s illegal in Kansas. Even having a small amount is considered a crime.
Why Aurora Cannabis Stock and Peers Are Struggling
Aurora Cannabis (ACB) had a hard time this year. ACB stock had been investors’ favorite in 2018. The stock started off 2019 on a good note
Canopy Growth: Why PI Financial Suggests a ‘Sell’
Canopy Growth dragged its stock down after its unimpressive end to fiscal 2020. The company missed the revenue estimates by a huge margin.
Marijuana: Why Is Washington Changing Its Laws?
In 2012, Washington was the second state to legalize recreational marijuana. Now, the state plans to revamp its marijuana laws.
How Was 2017 for European Markets?
At the start of 2017, elections in many European countries brought some political uncertainty to the European markets.
Canopy Growth Gets an Upgrade, Constellation Books Losses
Canopy Growth (CGC) (WEED) received optimistic views from analysts on Monday. Seaport Global Securities upgraded the stock to “buy” from “neutral.”
Joe Biden Won’t Legalize Cannabis—Why?
Although Joe Biden supported medical cannabis in his previous presidential campaigns, he has always opposed full-scale legalization.
Marijuana in Texas: Five Things You Should Know
Marijuana laws are pretty strict in Texas, but could this change? Here are five things you need to know about the state’s relationship with marijuana.
Why Canopy Growth Is Partnering with Drake
The Canadian Press reported that Canopy Growth is partnering with rapper Drake to launch a new cannabis venture, the More Life Growth Company.
Is 3M Stock Bearing the Burden as the Trade War Intensifies?
Since 3M Company’s second-quarter earnings release on July 25, its stock is down 7.5% as of August 5. What’s causing the fall?
Which Cannabis Stocks Have Lost More than 40% in 2019?
The cannabis industry has been on a rollercoaster ride this year. CannTrust, Tilray, and KushCo stocks have fallen more than 40% in 2019.
Cannabis Legalization: Is It Time for the US to Act?
Cannabis legalization has America’s attention. A Gallup survey has shown that two-thirds of Americans want cannabis legalized now.
Cannabis 2.0 Legalization: Canada Is Ready
Federally, cannabis legalization saw daylight in Canada in 2018. The Cannabis Act legalized recreational marijuana in October 2018. Now, the country is all set for the second wave of legalization, Cannabis 2.0, which includes cannabis edibles, cannabis-infused beverages, extracts, and various other products. Let’s dig into this more. Canada’s second wave of legalization Next month, […]
Cannabis Beverages: Why Canadians Can’t Wait
Deloitte estimates that the newly legalized cannabis beverage market could be worth 529 million Canadian dollars annually in Canada.
No Cannabis Edibles in Three Provinces for Christmas
After Canada legalized cannabis edibles in October, consumers hoped to buy these products this month. However, three provinces must wait until January.
Cannabis 2.0: Aurora Cannabis Gears Up for Edibles Market
Cannabis 2.0 legalization will take place in Canada next month. Cannabis players are gearing up to expand in the edibles market.
Key Events for Consumer Stocks: January 22–26
On January 16, 2018, Goldman Sachs upgraded Procter & Gamble (PG) to a “neutral” from a “sell” and increased the target price for the stock to $88 from $83.
Will Aurora Cannabis Turn the Corner in 2020?
Despite being prepared after Canada legalized recreational cannabis in 2018, Aurora Cannabis struggled to hit its revenue numbers.
Marijuana Campaigns Continue in Nebraska and Montana
Nebraska needs to collect 130,000 valid signatures from registered voters by July 8 to qualify recreational marijuana legalization for the November 2020 ballot.
Bunge Expects Resurgence of Commodities to Drive 2016 Growth
Bunge’s (BG) 1Q16 earnings were consistent with its guidance and beat earnings estimates by 78%.
Acreage Holdings Posts Disappointing Results in Q1 2020
Acreage Holdings’ first-quarter pro forma revenue grew 65% YoY (year-over-year) to $37.6 million. The revenue beat analysts’ estimates of $34.9 million.
Why Aurora Cannabis Wants to Grow Cannabis Outdoors
Aurora Cannabis (ACB) wants to grow cannabis outdoors. In July, it received Health Canada licenses for outdoor cultivation at two Canadian sites.
Could Certain Marijuana Strains Help Fight COVID-19?
The cannabis industry is doing its own research amid COVID-19. Researchers discovered that marijuana might have properties to fight the coronavirus.
How to Invest in Cannabis
Is Aurora Cannabis Ready for Cannabis 3.0?
Aurora Cannabis (ACB) is ready to launch its new products for Cannabis 2.0. But is the company ready for the next phase? Let’s find out.
Key Events for Consumer Stocks: February 12–16
On February 5, Jefferies upgraded Lowe’s (LOW) to “buy” from “hold” and raised the target price to $129 from $81.
Cannabis Legalization: The World Waits for the US
Cannabis legalization is spreading its roots globally. Considering that other countries are legalizing marijuana, will the US follow suit?
What’s Canopy Growth Strategy for Growth?
Canopy Growth has struggled this year. Despite all their strategies, cannabis companies have failed to hit revenue and profitability targets this year.
IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks
It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.
Key Dates for Consumer Stocks in the First Week of October
On September 28, Goldman Sachs upgraded Brown-Forman (BF-B) to “neutral” from “sell” and raised the target price to $56 from $51.
Arizona’s Marijuana Campaign Qualifies for November Ballot
Marijuana campaigns in most US states faced challenges gathering enough signatures amid the pandemic. However, Arizona got plenty of signatures.
Marijuana Legalization: What’s Happening in Utah?
Recreational cannabis isn’t legal in Utah. Although the state legalized medical cannabis in 2018, the medical marijuana program will go live in March 2020.
Aurora Cannabis: Is This the Right Time to Invest?
Amid a subdued cannabis sector, Aurora Cannabis (ACB) stock has taken a serious hit and is down 36.4% this month. Is this the right time to invest?
Illinois’ Cannabis Sales Soared in June: Which Stocks Will Benefit?
Cannabis sales have been soaring in all of the US states that classified it as an “essential item” amid the pandemic. Illinois has seen tremendous growth.
Tilray’s Q2 Earnings Are Out: Did It Impress?
In its Q2 earnings report today, Tilray reported a 371% YoY revenue increase to $45.9 million. Tilray beat analysts’ estimate of $41.1 million in revenue.
Has Irwin Simon Really Turned Aphria Around?
Aphria (APHA) has impressed investors with its earnings results this year. Overall, the cannabis industry has struggled due to various headwinds.
Do Republicans Want to Join the Cannabis Action?
Republicans have been conservative about cannabis. However, cannabis legalization is a popular discussion topic among Democrats.
Will Marijuana Stocks Continue to Surge in June?
May was an earnings month for many marijuana companies. Notably, US companies showed better revenue growth than their Canadian peers.
Canopy Growth and Cronos Group’s Earnings Next Week
Canopy Growth (CGC) (WEED) and Cronos Group (CRON) are set to release their earnings next week. The cannabis sector has been on a roller coaster this year.